PRESS RELEASE
Data on 53 Patients Treated With Investigational Antiviral Remdesivir Through the Compassionate Use Program Published in New England Journal of Medicine
April 10, 2020 at 3:31 PM EDT
— Remdesivir treatment resulted in clinical improvement in 68 percent of patients in this limited data set —
FOSTER CITY, Calif.–(BUSINESS WIRE)–Apr. 10, 2020– Gilead Sciences, Inc. (Nasdaq: GILD) today announced results from a cohort analysis of 53 patients hospitalized with severe complications of COVID-19 who …
The post GILEAD: Data on 53 Patients Treated with investigational antiviral Remdesivir through the compassionate use program published in New England Journal of Medicine appeared first on The Loadstar.
Source: The Loadstar
Be the first to comment on "GILEAD: Data on 53 Patients Treated with investigational antiviral Remdesivir through the compassionate use program published in New England Journal of Medicine"